Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.1B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.04B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.02B |
| 4 |
iShares China Large-Cap ETF
FXI
|
+$255M |
| 5 |
ARK Innovation ETF
ARKK
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$430M |
| 2 |
Microsoft
MSFT
|
+$365M |
| 3 |
Intel
INTC
|
+$335M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$333M |
| 5 |
Mercado Libre
MELI
|
+$309M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.43% |
| 2 | Healthcare | 5.69% |
| 3 | Financials | 4.7% |
| 4 | Consumer Discretionary | 4.61% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Lincoln Electric
LECO
$14.1B
| $2.81M | ﹤0.01% |
16,607
-1,292
| -7% | -$213K |
|
1777
Cenovus Energy
CVE
$54.2B
| $2.8M | ﹤0.01% |
160,890
+51,451
| +47% | +$944K |
|
1778
Banco Santander
SAN
$191B
| $2.79M | ﹤0.01% |
757,351
-58,357
| -7% | -$208K |
|
|
TSP
1779
CALL
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $2.79M | ﹤0.01% |
1,900,000
| – | – |
|
1780
Comfort Systems
FIX
$53.5B
| $2.78M | ﹤0.01% |
19,053
-10,233
| -35% | -$1.33M |
|
1781
Par Pacific Holdings
PARR
$4.17B
| $2.78M | ﹤0.01% |
95,212
-68,776
| -42% | -$1.84M |
|
1782
Unum
UNM
$13.2B
| $2.77M | ﹤0.01% |
70,142
+12,730
| +22% | +$526K |
|
1783
iShares MSCI Canada ETF
EWC
$6.12B
| $2.77M | ﹤0.01% |
81,150
-31,027
| -28% | -$1.06M |
|
1784
PUT
Goodyear
GT
$2.09B
| $2.75M | ﹤0.01% |
250,000
+15,100
| +6% | +$167K |
|
1785
Flex
FLEX
$37.7B
| $2.75M | ﹤0.01% |
158,868
+15,090
| +10% | +$261K |
|
1786
Allogene Therapeutics
ALLO
$625M
| $2.74M | ﹤0.01% |
555,343
+210,972
| +61% | +$1.35M |
|
1787
Kilroy Realty
KRC
$4.59B
| $2.72M | ﹤0.01% |
83,946
+37,325
| +80% | +$1.36M |
|
|
CLVT.PRA
1788
DELISTED
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
| $2.72M | ﹤0.01% |
66,150
+41,779
| +171% | +$1.88M |
|
|
EXAS
1789
CALL
DELISTED
Exact Sciences
EXAS
| $2.71M | ﹤0.01% |
+40,000
| New | +$2.57M |
|
1790
Kura Oncology
KURA
$793M
| $2.7M | ﹤0.01% |
220,988
+76,397
| +53% | +$953K |
|
1791
CALL
Sherwin-Williams
SHW
$83.5B
| $2.7M | ﹤0.01% |
12,000
-6,300
| -34% | -$1.44M |
|
1792
LGI Homes
LGIH
$1.35B
| $2.69M | ﹤0.01% |
23,623
-147
| -0.6% | -$16K |
|
|
ROIC
1793
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $2.69M | ﹤0.01% |
192,683
+59,699
| +45% | +$867K |
|
1794
Mobileye
MBLY
$2.02B
| $2.69M | ﹤0.01% |
62,112
+34,776
| +127% | +$1.36M |
|
1795
Webster Financial
WBS
$12.3B
| $2.69M | ﹤0.01% |
68,157
-6,099
| -8% | -$293K |
|
1796
LXP Industrial Trust
LXP
$3.52B
| $2.68M | ﹤0.01% |
52,080
+4,954
| +11% | +$265K |
|
1797
Arcutis Biotherapeutics
ARQT
$3.48B
| $2.68M | ﹤0.01% |
243,999
+110,771
| +83% | +$1.6M |
|
|
RXDX
1798
CALL
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $2.68M | ﹤0.01% |
+25,000
| New | +$2.88M |
|
|
RXDX
1799
PUT
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $2.68M | ﹤0.01% |
+25,000
| New | +$2.88M |
|
|
TSVT
1800
DELISTED
2seventy bio
TSVT
| $2.68M | ﹤0.01% |
262,976
+198,403
| +307% | +$2.27M |
|
Similar funds
Citigroup's Q1 2023 Portfolio in Review
As of Q1 2023, Citigroup held 6,117 positions worth $143B, up 14% from $126B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Citigroup deployed $6.55B of net new capital in Q1 2023, opening 347 new positions and adding to 2,011 existing holdings. Its largest new stake was Direxion Daily S&P 500 Bull 2X ETF: 350,003 shares worth $28M.
By sector, the portfolio is most concentrated in Technology at 9.4% of assets, down from 9.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street Consumer Staples Select Sector SPDR ETF, an estimated $430M trimmed.
- Citigroup's largest Q1 2023 buy was Direxion Daily S&P 500 Bull 2X ETF: 350,003 shares worth $28M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $1.1B increase.
- Citigroup's biggest Q1 2023 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $430M.
- Citigroup fully exited LHC Group LLC in Q1 2023, selling an estimated $28.8M.
- Citigroup's ten largest holdings make up 34% of its $143B portfolio in Q1 2023.
- Citigroup opened 347 new positions and closed 668 in Q1 2023.
- Citigroup's portfolio value rose 14% quarter-over-quarter to $143B.
Based on Citigroup's 13F filing for Q1 2023, filed 11 May 2023.